Join Thomas W. Flaig, MD and Shandra Wilson, MD from University of Colorado Cancer Center as they present their expertise on a range of cases pertaining to bladder cancer.

Join Thomas W. Flaig, MD and Shandra Wilson, MD from University of Colorado Cancer Center as they present their expertise on a range of cases pertaining to bladder cancer.

The 2017 NCCN Nursing Program: Advancing Oncology Nursing Live Webinar Series will provide oncology nurses with comprehensive and clinically relevant information to optimize patient education and care.

The 2017 NCCN Nursing Program: Advancing Oncology Nursing Live Webinar Series will provide oncology nurses with comprehensive and clinically relevant information to optimize patient education and care.

The goal of this activity is to increase participants’ knowledge of immune checkpoint inhibitors and improve competence and performance in the safe and effective integration of these agents in the treatment of renal cell carcinoma and urothelial carcinoma.

This information was originally presented at the NCCN 22nd Annual Conference: Improving the Quality, Effectiveness, and Efficiency of Cancer Care™ held in Orlando, Florida, from March 23 - 25, 2017.

The goal of this activity is to increase participants’ ability to use immune checkpoint inhibitors for management of individual patients with urothelial cell and renal cell carcinoma to improve clinical outcomes and quality of life.

The goal of this activity is to increase participants’ ability to use immune checkpoint inhibitors for management of individual patients with urothelial cell and renal cell carcinoma to improve clinical outcomes and quality of life.

These NCCN Guidelines Insights discuss the major recent updates to the NCCN Guidelines for Bladder Cancer based on the review of the evidence in conjunction with the expert opinion of the panel.

Join David D. Chism, MD, MS and Peter E. Clark from Vanderbilt-Ingram Cancer Center as they present their expertise on a range of cases pertaining to bladder cancer.